Expanded indication provides patients with knee osteoarthritis the benefits of Embosphere’s consistent, predictable, and effective clinical results. SOUTH JORDAN, Utah, Sept. 12, 2025 (GLOBE NEWSWIRE) ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Leading manufacturer and marketer of proprietary disposable devices, Merit Medical Systems, Inc. MMSI recently announced the receipt of 513(f)(2) (de novo) classification for Embosphere Microspheres ...
SOUTH JORDAN, Utah, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that Embosphere ® Microspheres are now ...
Merit Medical Systems MMSI has secured a major regulatory milestone with the CE Mark approval of its Embosphere Microspheres for genicular artery embolisation (GAE) to treat knee osteoarthritis (OA).
Performed by an interventional radiologist, GAE selectively reduces blood flow to the inflamed synovium (thin lining within the joint), offering meaningful reductions in knee pain, improved joint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results